Key result
Anthracycline-containing regimens remain superior to taxane-alone regimens in terms of recurrence and mortality for early breast cancer, though their use must be balanced against toxicity risks.
Why the study?
Benefits of potent anthracycline schedules for early breast cancer must be balanced against short- and long-term toxicity to individualize treatment options.
Do anthracycline-based chemotherapy regimens improve efficacy compared to non-anthracycline regimens in patients with early breast cancer?
Do anthracycline-based chemotherapy regimens improve efficacy compared to non-anthracycline regimens in patients with early breast cancer?
This review highlights the need to individualize early breast cancer treatment by balancing the potent efficacy of anthracyclines against their significant risks of cardiotoxicity and secondary leukemia.
Supports individualized anthracycline decisions in early breast cancer; leaves open refined selection via contemporary RCTs.
Standard chemotherapy for early breast cancer consists generally of an anthracycline - taxane - based regimen, preferably in sequence. Anthracyclines are among the most active cytotoxic drugs against breast cancer. Nevertheless, benefits attained by the use of the more potent anthracycline schedules must be balanced against increased short - and long - term toxicity, and treatment options must be individualized for each patient. Authors review available data regarding anthracycline efficacy and toxicity in the early breast cancer setting and the potential directions for future research.
No takes yet. Share an insight, caveat, or question.
Vuger et al. (2022) conducted a review in Early breast cancer. Anthracyclines vs. Non-anthracycline regimens was evaluated. Anthracycline-containing regimens remain superior to taxane-alone regimens in terms of recurrence and mortality for early breast cancer, though their use must be balanced against toxicity risks.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: